Article

Navigating An Ever-Changing Landscape: The Role Of A CFO In A Private Equity Controlled Pharma Company

Source: Pharmaceutics International

By Kurt R. Nielsen, Ph.D., President and CEO, Pharmaceutics International, Inc (Pii)

iStock-1200038380-stock-finance-chart-CFO

The role of Chief Financial Officer for a small-to-mid size pharma company controlled by private equity is a challenging one. It requires balancing the competing demands of the Board of Directors, other executives, staff, and investors or shareholders.

However, most small-to-mid-size pharma companies with limited internal resources rely on CDMOs for support and they can be a great help to CFOs.

Kurt Nielsen, CEO of Pharmaceutics International shares his thoughts on how CFOs of pharma companies controlled by private equity can use their CDMOs to be more successful.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: